• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰怀卡托地区巨细胞动脉炎的流行病学。

Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.

机构信息

Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand.

Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Waikato Clinical School, The University of Auckland, Hamilton, New Zealand.

出版信息

N Z Med J. 2024 Mar 22;137(1592):14-21. doi: 10.26635/6965.6379.

DOI:10.26635/6965.6379
PMID:38513200
Abstract

AIM

Giant cell arteritis (GCA) is the most common primary vasculitis in adults over 50 years of age. Our primary objective was to assess the incidence and prevalence of GCA in Waikato in a bid to deepen our understanding of the epidemiology of GCA in Aotearoa New Zealand.

METHODS

From January 2014 to December 2022, cases of GCA were identified prospectively and retrospectively through temporal artery ultrasound request lists and temporal artery biopsy histology reports. Using electronic health records, data were collected retrospectively on patient demographics and clinical features. These were used to calculate the incidence, prevalence and standardised mortality ratio (SMR) of GCA in Waikato.

RESULTS

There were 214 patients diagnosed with GCA over the 9-year period. The majority of patients were European (93.9%, 201/214) with Māori patients being significantly younger than European patients. The mean annual incidence of clinical GCA was 14.7 per 100,000 people over 50 years (95% confidence interval [CI] 12.7-16.6). The SMR was 1.18 (95% CI 0.83-1.52).

CONCLUSION

This is the largest study to date on the epidemiology of GCA in Aotearoa New Zealand. The incidence of GCA is comparable to other studies performed in Aotearoa New Zealand and appears to be stable over time. GCA is uncommon in Māori, Pacific Islander and Asian ethnic groups.

摘要

目的

巨细胞动脉炎(GCA)是 50 岁以上成年人中最常见的原发性血管炎。我们的主要目标是评估怀卡托地区 GCA 的发病率和患病率,以期加深我们对新西兰 GCA 流行病学的理解。

方法

从 2014 年 1 月至 2022 年 12 月,通过颞动脉超声检查申请列表和颞动脉活检组织学报告前瞻性和回顾性地确定 GCA 病例。使用电子健康记录,回顾性收集患者的人口统计学和临床特征数据。这些数据用于计算怀卡托地区 GCA 的发病率、患病率和标准化死亡率比(SMR)。

结果

在 9 年期间,共诊断出 214 例 GCA 患者。大多数患者为欧洲人(93.9%,201/214),毛利人患者明显比欧洲人患者年轻。50 岁以上人群临床 GCA 的年平均发病率为 14.7/10 万人(95%置信区间 [CI] 12.7-16.6)。SMR 为 1.18(95%CI 0.83-1.52)。

结论

这是迄今为止关于新西兰 GCA 流行病学的最大研究。GCA 的发病率与在新西兰进行的其他研究相当,且似乎随时间保持稳定。GCA 在毛利人、太平洋岛民和亚裔人群中较为少见。

相似文献

1
Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.新西兰怀卡托地区巨细胞动脉炎的流行病学。
N Z Med J. 2024 Mar 22;137(1592):14-21. doi: 10.26635/6965.6379.
2
Tocilizumab for giant cell arteritis.托珠单抗治疗巨细胞动脉炎。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013484. doi: 10.1002/14651858.CD013484.pub3.
3
Tocilizumab for giant cell arteritis.托珠单抗治疗巨细胞动脉炎。
Cochrane Database Syst Rev. 2021 Aug 22;8(8):CD013484. doi: 10.1002/14651858.CD013484.pub2.
4
Re: Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.主题:新西兰怀卡托地区巨细胞动脉炎的流行病学研究 # 解析 这是一封电子邮件的主题,原文是英文,译文准确传达了原文的内容,符合中文的表达习惯。
N Z Med J. 2024 Apr 12;137(1593):93-95. doi: 10.26635/6965.6568.
5
Discrepancies in Temporal Artery Biopsy Positivity Rate Among White and Black Patients Suspected of Having Giant Cell Arteritis.疑似巨细胞动脉炎的白人和黑人患者颞动脉活检阳性率的差异。
J Clin Rheumatol. 2025 Jun 1;31(4):166-169. doi: 10.1097/RHU.0000000000002205. Epub 2025 Jan 31.
6
A scoping review of ear and hearing health research in Aotearoa New Zealand: a focus on equity.新西兰奥塔哥地区耳与听力健康研究的范围综述:聚焦公平性
J R Soc N Z. 2025 Jan 15;55(3):611-632. doi: 10.1080/03036758.2024.2435394. eCollection 2025.
7
Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand.新西兰奥特亚罗瓦坎特伯雷地区类风湿关节炎的发病率、患病率和死亡率。
Intern Med J. 2025 Jul;55(7):1161-1168. doi: 10.1111/imj.70068. Epub 2025 Apr 15.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence.新西兰怀卡托地区的炎症性肠病:发病率和患病率。
Intern Med J. 2023 Dec;53(12):2307-2312. doi: 10.1111/imj.16072. Epub 2023 Mar 27.
10
Ethnic differences in the characteristics of patients with newly diagnosed lung cancer in the Te Manawa Taki region of New Zealand.新西兰特曼纳瓦塔基地区新诊断肺癌患者特征的种族差异。
Intern Med J. 2024 Mar;54(3):421-429. doi: 10.1111/imj.16202. Epub 2023 Aug 16.

引用本文的文献

1
Chronic cyanosis since infancy: Unveiling a giant right pulmonary arteriovenous malformation.自婴儿期起的慢性紫绀:揭示巨大的右肺动静脉畸形。
Radiol Case Rep. 2025 Aug 5;20(10):5353-5356. doi: 10.1016/j.radcr.2025.06.084. eCollection 2025 Oct.
2
The Set up and the Triggers: An Update on the Risk Factors for Giant Cell Arteritis.发病机制与触发因素:巨细胞动脉炎危险因素的最新进展
Curr Neurol Neurosci Rep. 2024 Dec 14;25(1):11. doi: 10.1007/s11910-024-01386-3.